The M&A Advisor Recognizes WilmerHale in Annual Turnaround Awards

The M&A Advisor Recognizes WilmerHale in Annual Turnaround Awards

Recognition

Related Solutions

WilmerHale has been at the forefront of complex financial restructuring and bankruptcy litigation and policy matters for decades.
Advising life sciences innovators, investors and industry leaders on complex transactions, legal issues and business challenges.
WilmerHale lawyers have decades of experience advising public and private companies in all aspects of mergers and acquisitions.
A deep and diverse practice focused on maximizing tax efficiencies and minimizing tax risks for clients nationally and internationally.

The M&A Advisor honored WilmerHale with the Chapter 11 Reorganization Award as part of its 14th Annual Turnaround Awards. The firm was recognized for its work in advising Argos Therapeutics in an asset sale. The nominations, representing 240 companies, were reviewed by an independent panel of industry leaders. The awards will be presented at a virtual event on November 10, 2020.

“These award winners are representative of those that reached the pinnacle of the distressed investing, bankruptcy and reorganization industry for 2019. They earned these honors by standing out in a group of very impressive candidates,” said Roger Aguinaldo, Founder of The M&A Advisor. “In an environment that is increasingly demanding of its professionals, we are recognizing the leading transactions, firms and individuals that represent the highest levels of performance.”

The WilmerHale team recognized for advising Argos Therapeutics includes George Shuster, Benjamin Loveland, Lauren Lifland, Stuart Falber and Robert Burke.

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.

I Accept Cancel